AD
Enfuvirtide(CAS: 159519-65-0)
CAS Number
Related Products
3-Acetoxy-4-cadinen-8-one
CAS Number: 923950-05-4
4-Oxo-1-phenylcyclohexanecarbonitrile
CAS Number: 25115-74-6
Valiolamine
CAS Number: 83456-22-9
2-(1-Pyrrolidinyl)ethanamine
CAS Number: 7154-73-6
5-(Diethylamino)-1-pentanol
CAS Number: 2683-57-0
![2-Methyl-2-propanyl 4-{[2-(2-aminophenyl)ethyl]amino}-1-piperidinecarboxylate](https://static.chemtradehub.com/structs/783/783368-12-7-e061.webp)
Benzenemethanol, 4-nitro-, 1-acetate
CAS Number: 619-90-9
Other Suppliers for Enfuvirtide
Basic Information
Molecular Formula
C204H301N51O64
Molecular Weight
4491.92 g/mol
EINECS
641-385-0
Physical Properties
Boiling Point
°Cat760mmHg
Density
1.59
Flash Point
°C
Chemical Identifiers
SMILES
CC[C@@H]([C@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC(C)=O)CC1=CC=C(O)C=C1)=O)[C@H](O)C)=O)CO)=O)CC(C)C)=O)[C@H](CC)C)=O)CC2=CN=CN2)=O)CO)=O)CC(C)C)=O)C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N)=O)CC3=CC=CC=C3)=O)CC4=CNC5=CC=CC=C45)=O)CC(N)=O)=O)CC6=CNC7=CC=CC=C67)=O)CC(C)C)=O)CO)=O)C)=O)CC8=CNC9=CC=CC=C89)=O)CCCCN)=O)CC(O)=O)=O)CC(C)C)=O)CCC(O)=O)=O)CC(C)C)=O)CC(C)C)=O)CCC(O)=O)=O)CCC(N)=O)=O)CCC(O)=O)=O)CC(N)=O)=O)CCCCN)=O)CCC(O)=O)=O)CCC(N)=O)=O)CCC(N)=O)=O)CC(N)=O)=O)CCC(N)=O)=O)CO)=O)CCC(O)=O)=O)CCC(O)=O)=O)C
InChIKey
PEASPLKKXBYDKL-FXEVSJAOSA-N
Database References
MDL Number
MFCD08704781
FAQ
Enfuvirtide (CAS: 159519-65-0) is regulated under the Globally Harmonized System (GHS) and is classified as a pharmaceutical drug. Regulatory guidelines include compliance with REACH regulations for supply chain information, as well as FDA and EPA requirements for labeling and handling. Ensuring proper documentation and safety measures are in place is critical for compliance.
While Enfuvirtide (CAS: 159519-65-0) is a specific drug and not a chemical compound, alternatives in terms of synthesis involve using analogs such as chemically modified peptides or alternative antiretroviral drugs. Common alternative reagents include different amino acids or synthetic intermediates, but these are typically explored in research settings.
Enfuvirtide (CAS: 159519-65-0) has seen declining market interest due to the availability of newer, more effective antiretroviral therapies. Research trends focus on understanding its mechanisms of action and potential repurposing for other conditions, with a focus on its immunomodulatory properties.
Waste containing Enfuvirtide (CAS: 159519-65-0) should be handled as a hazardous pharmaceutical waste. Collect waste in appropriate containers, labeled with the substance's identity and concentration. Incineration or professional waste disposal services are recommended to ensure safe disposal and minimize environmental impact. Follow local and national regulations for hazardous waste management.
Safety Notice
Please verify product specifications and safety data before use. Contact the supplier for detailed safety information.
Always follow proper handling procedures
Contact Information
hepeng20160718@foxmail.com
Mobile
13122891558
Telephone
186-16545970
Visit Website
https://www.hepengbio.com/